Tromsø, Norway

Elisabeth Lill Andreassen



 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Elisabeth Lill Andreassen: Innovator in Exonuclease Technology

Introduction

Elisabeth Lill Andreassen is a notable inventor based in Tromsø, Norway. She has made significant contributions to the field of biotechnology, particularly in the development of thermolabile exonucleases. With a total of 3 patents to her name, her work has implications for various applications in molecular biology.

Latest Patents

One of her latest patents focuses on thermolabile exonucleases. This invention provides an exonuclease or an enzymatically active fragment that has a specific amino acid sequence. The exonuclease is designed to be substantially irreversibly inactivated by heating at a temperature of about 55°C for 10 minutes in a specific buffer. It is substantially specific for single-stranded DNA and exhibits 3'-5' exonuclease activity. The invention also outlines methods for removing single-stranded DNA from samples, nucleic acid amplification, reverse transcription, and nucleic acid sequence analysis. Additionally, it includes nucleic acids encoding the exonuclease and kits or compositions comprising the same.

Career Highlights

Elisabeth has worked with prominent organizations such as Arcticzymes AS and the University of Tromsø—Norges Arktiske Universitet. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Throughout her career, Elisabeth has collaborated with notable colleagues, including Terese Solstad and Marit Sjo Lorentzen. These partnerships have enriched her work and fostered innovation in her field.

Conclusion

Elisabeth Lill Andreassen is a pioneering inventor whose work in thermolabile exonucleases has the potential to impact various areas of molecular biology. Her contributions continue to advance the understanding and application of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…